andexanet alfa

CHEBI:CHEBI_749080

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

generic_name
andexanet alfa
rxcui
2108130
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20251231
route
INTRAVENOUS
dosage_form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
marketing_category
BLA
active_ingredient_strength
200 mg/20mL
labeler_name
AstraZeneca Pharmaceuticals LP
manufacturer_name
AstraZeneca Pharmaceuticals LP
marketing_start_date
20220712
package_marketing_start_date
20230703
brand_name
ANDEXXA
brand_name_base
ANDEXXA
product_ndc
0310-3200
application_number
BLA125586
spl_id
0bbb6c1a-65b2-480a-8360-e70322ccd510
active_ingredient_name
ANDEXANET ALFA
package_ndc
0310-3200-05
package_description
5 VIAL, SINGLE-USE in 1 CARTON (0310-3200-05) / 20 mL in 1 VIAL, SINGLE-USE (0310-3200-01)
unii
BI009E452R
spl_set_id
2d9d90a6-63e6-46ef-96ff-dd6519ae7b6c
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class